雑誌文献を検索します。書籍を検索する際には「書籍検索」を選択してください。

検索

書誌情報 詳細検索 by 医中誌

Japanese

New Development in Osteoporosis Treatment. Anti-Dickkopf1(Dkk1)antibody as a bone anabolic agent for the treatment of osteoporosis. Tai Nobuyuki 1 , Inoue Daisuke 2 1Third Department of Medicine, Teikyo University School of Medicine, Japan. 2Third Department of Medicine, Teikyo University School of Medicine, Japan. pp.75-83
Published Date 2013/12/28
DOI https://doi.org/10.20837/4201401075
  • Abstract
  • Look Inside
  • Reference

 Wnt/β-catenin signaling pathway plays an important role in bone metabolism. This signal is subject to strict regulation, involving endogenous soluble inhibitors. Dkk1 is a member of family of secreted protein which functions in head induction during Xenopus embryogenesis. Dkk1 forms a ternary complex with LRP5/6 and Kremen, resulting in suppression of Wnt signaling and decreased bone formation. Heterozygous knockout mice of Dkk1 show high bone mass, while transgenic mice overexpressing Dkk1 exhibit low bone mass phenotype. Anti-Dkk1 monoclonal antibody has been shown to accelerate bone formation and increase bone mineral density in various animal models and is under development as a bone-anabolic agent.



基本情報

電子版ISSN 印刷版ISSN 0917-5857 医薬ジャーナル社

関連文献

もっと見る

文献を共有